未登录Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study
El Badri, Salma; Tahir, Bilal; Balachandran, Kirsty; Bezecny, Pavel; Britton, Fiona; Davies, Mark; Desouza, Karen; Dixon, Simon; Hills, Daniel; Moe, Maung; Pigott, Thomas; Proctor, Andrew; Shah, Yatri; Simcock, Richard; Stansfeld, Anna; Synowiec, Alicja; Theodoulou, Marianna; Verrill, Mark; Wadhawan, Anshu; Harper-Wynne, Catherine; Wilson, Caroline
分享
收藏Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER plus ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: A real-world multicentre UK study
El Badri, S.; Tahir, B.; Balachandran, K.; Bezecny, P.; Britton, F.; DeSouza, K.; Hills, D.; Moe, M.; Pigott, T.; Proctor, A.; Shah, Y.; Simcock, R.; Stansfeld, A.; Synowiec, A.; Theodoulou, M.; Verrill, M.; Wadhawan, A.; Harper-Wynne, C.; Wilson, C.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏